Head-to-head · WeighScore
Hers vs ShedRx
The verdict
ShedRx takes it — 87/100 to 60.7/100.
ShedRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. The widest formulation spread in the ranking — injection, drops, lozenges and a daily oral pill, plus a real brand Zepbound lane.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Hers | ShedRx |
|---|---|---|
| WeighScore | 60.7/100 | 87/100 |
| Grade | C | B+ |
| Site position | #359 | #3 |
| Semaglutide | From $149/mo (Wegovy pill; plus required care: $39 first month, then $149/mo) | $199/mo |
| Tirzepatide | From $299/mo (Zepbound vial or KwikPen; plus required care: $39 first month, then $149/mo) | $299/mo |
| Coverage | Not available in every state; confirm eligibility | All 50 states |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Yes | Yes |
Site position #359 · C
FDAWarning letter issued to Hims & Hers Health, Inc. dba Hers in September 2025. See the FDA warning-letter database.
Strengths
- Branded Wegovy pill and pen, plus Zepbound vial or KwikPen options listed
- Ongoing provider messaging and monthly care-team follow-ups described
- Published membership and medication charges can be compared separately
What to consider
- Required care membership is $39 first month, then $149 monthly, extra to medication
- Membership and medication cancellation are separate; shipped prepaid supply may keep membership charges payable
- Availability and medication prices depend on state, product, dose and plan
- FDA issued Hims & Hers Health, Inc. dba Hers a warning letter in September 2025 concerning compounded-semaglutide promotion; this is distinct from current branded-product approval
Site position #3 · B+
Strengths
- Four GLP-1 routes — injection, liquid drops, lozenges and an oral daily pill
- Brand Zepbound and Wegovy available beside the compounded line
- Health coaching included with membership, plus a published 120-day weight-loss guarantee
What to consider
- The advertised "as low as $239" tirzepatide rate requires a twelve-month commitment — month-to-month is $299
- Compounded medication is not FDA-approved the way brand Ozempic, Wegovy, or Zepbound are
- The dispensing compounding pharmacy is not publicly named
Featured provider
ShedRx
ShedRx scores 87/100 (B+). The widest formulation spread in the ranking — injection, drops, lozenges and a daily oral pill, plus a real brand Zepbound lane.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.